RxDoctor Payments Data

Edgar Domenech Fagundo, MD

Plastic Surgery within the Head & Neck · Ponce, PRNPI 1386717247

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 25.0% of the total. 2025 is the largest year on record at $615, 3.1 times the $200 reported in 2019.

$1,907in general payments, 2019–2025

Across 41 payments — averaging $46.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$476
  • Medtronic$448
  • Boston Scientific$316
  • E.r. Squibb & Sons, L.L.C.$170
  • Bard Peripheral Vascular, Inc.$124
  • Dexcom, Inc.$114
  • plus $259 from 6 others

What the payments were for

  • Food & beverage$1,907100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson11$476
Medtronic11$448
Boston Scientific6$316
E.r. Squibb & Sons, L.L.C.2$170
Bard Peripheral Vascular, Inc.1$124
Dexcom, Inc.1$114
Baxter Healthcare1$68
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$61
BD2$56
Johnson And Johnson International1$37
PBG Puerto Rico LLC1$23
Olympus Latin America, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$14,569
Medicare patients
66
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinolone Acetonide Oil120$9,109
Azelastine-FluticasoneAzelastine/Fluticasone82$7,745
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort67$4,735
SynthroidLevothyroxine Sodium59$3,431
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$2,253
Lansoprazole140$2,063
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort29$1,963
Fluticasone Propionate80$1,587
Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid11$1,465
Azelastine Hcl52$1,256
Ofloxacin18$768
Famotidine115$717
Cefadroxil37$417
Levocetirizine Dihydrochloride31$387
Cefdinir14$367

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Ponce

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →